Enlivex Stock: A Very Enticing Early-Stage Biotech (NASDAQ:ENLV)
Artur Plawgo/iStock via Getty Images Enlivex Therapeutics (NASDAQ:ENLV) is a clinical stage pharmaceutical company developing a single drug candidate called Allocetra—an off-the-shelf, scalable, and affordable cell therapy which has been designed to reprogram macrophages in […]
